Figure 1: 18F-fluorodeoxyglucose positron-emission tomography/computed tomography showing intense fluorodeoxyglucose uptake in the heterogeneously enhancing soft-tissue lesion in the body and fundus of the uterus highlighted with arrow (Maximum intensity projection (MIP); a, axial fused positron-emission tomography computed tomography; b and axial computed tomography; c). fluorodeoxyglucose avid wall thickening in the left posterolateral wall of the urinary bladder (broken arrow in axial fused positron-emission tomography computed tomography; d and axial contrast-enhanced computed tomography; e)
